Psychedelic therapy training for mental health professionals

Learn to navigate non-ordinary states to better serve your clients

Beckley Academy prepares and trains providers to support patients to heal their mental health challenges with Ketamine, Psilocybin and MDMA.

FDA clinical trials for psychedelic-assisted therapy (PAT) with MDMA and Psilocybin have shown potential for treating PTSD, depression, anxiety and other mental health issues. Ketamine-Assisted Therapy is a legal treatment today. Approval for MDMA treatment and Psilocybin is expected in 2024 and 2026, respectively.




More about our first program:
Foundations of Psychedelic-Assisted Therapy (PAT)

Cohort begins March 13, 2023 and ends on June 30, 2023 

Drawing from the decades of research developed by the Beckley Foundation and Amanda Feilding, as well as the seminal work of Janis Phelps, Carl Jung, Stanislav Grof, Kylea Taylor, and Friederike Meckel Fischer, among others, Foundations of Psychedelic-Assisted Therapy presents psychoanalytical, psychodynamic, somatic, and transpersonal perspectives of the unconscious and shadow material that emerges in non-ordinary states of consciousness.

100% Online | 13 weeks | 60 hours | Intimate cohort | Accessible tuition